Broughton G, Janis JE, Attinger CE: A brief history of wound care. .Plast Reconstr Surg 117: (suppl):6S. ,2006. .
Attinger CE, Bulan E, Blume PA: Surgical debridement: the key to successful wound healing and reconstruction. .Clin Podiatr Med Surg 17::599. ,2000. .
Attinger CE, Janes JE, Steinberg JS, et al: Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. .Plast Reconstr Surg 117: (suppl):72S. ,2006. .
Armstrong DG, Lavery LA, Nixon BP, et al: It’s not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. .Clin Infect Dis 39: (suppl 2):S92. ,2004. .
Cardinal M, Eisenbud DE, Armstrong DG, et al: Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. .Wound Repair Regen 17::306. ,2009. .
Saap LJ, Falanga V: Debridement performance index and its correlation with complete closure of diabetic foot ulcers. .Wound Repair Regen 10::354. ,2002. .
Kumagi SG, Mahoney CR, Fitzgibbons TC, et al: Treatment of diabetic (neuropathic) foot ulcers with two-stage debridement and closure. .Foot Ankle Int 19::160. ,1998. .
Williams D, Enoch S, Miller D, et al: Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. .Wound Repair Regen 132::131. ,2005. .
Steed DL, Donohoe D, Webster MW, et al; Diabetic Ulcer Study Group: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. .J Am Coll Surg 183::61. ,1996. .
Brem H, Sheehan P, Rosenberg HJ, et al: Evidence-based protocol for diabetic foot ulcers. .Plast Reconstr Surg 117: (suppl):193S. ,2006. .
Piaggesi A, Schipani E, Campi F, et al: Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. .Diabet Med 15::4412. ,1998. .
Dryburgh N, Smith F, Donaldson J, et al: Debridement for surgical wounds. .Cochrane Database Syst Rev 3::CD006214. ,2008. .
Gottrup F: Debridement: another evidence problem in wound healing. .Wound Repair Regen 17::294. ,2009. .
James GA, Swogger E, Wolcott R, et al: Biofilms in chronic wounds. .Wound Repair Regen 16::37. ,2008. .
Broughton G II, Janis JE, Attinger CE: The basic science of wound healing. .Plast Reconstr Surg 117: (suppl):12S. ,2006. .
Panuncialman J, Falanga V: The science of wound bed preparation. .Surg Clin North Am 89::611. ,2009. .
Clark RA: Oxidative stress and “senescent” fibroblasts in non-healing wounds as potential therapeutic targets. .J Invest Dermatol 128::2361. ,2008. .
Vande Berg JS, Rose MA, Haywood-Reid PL, et al: Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta 1. .Wound Repair Regen 13::76. ,2005. .
Almqvist S, Werthen M, Johansson A, et al: Evaluation of near-senescent human dermal fibroblast cell line and effect of amelgenin. .Br J Dermatol 160::1163. ,2009. .
Mendez MV, Raffetto JD, Phillips T, et al: The proliferative capacity of neonatal fibroblasts is reduced after exposure to venous ulcer fluid: a potential mechanism for senescence in venous ulcers. .J Vasc Surg 30::734. ,1999. .
Harding KG, Moore K, Phillips TJ: Wound chronicity and fibroblast senescence: implications for treatment. .Int Wound J 2::364. ,2005. .
Stanley A, Osler T: Senescence and the healing rates of venous ulcers. .J Vasc Surg 33::1206. ,2001. .
Martin JM, Zenilman JM, Lazarus GS: Molecular microbiology: new dimensions for cutaneous biology and wound healing. .J Invest Dermatol 130::38. ,2010. .
Davis SC, Martinez L, Kirsner R: The diabetic foot: the importance of biofilms and wound bed preparation. .Curr Diab Rep 6::439. ,2006. .
Brady RA, Leid JG, Calhoun JH, et al: Osteomyelitis and the role of biofilms in chronic infection. .FEMS Immunol Med Microbiol 52::13. ,2008. .
Costerton W, Veeh R, Shirtliff M, et al: The application of biofilm science to the study and control of chronic bacterial infections. .J Clin Invest 112::1466. ,2003. .
Brem H, Golink MS, Stojadinovic O, et al: Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cells and test putative growth factor therapy such as GMCSF. .J Transl Med 6::75. ,2008. .
Kirsner R: Biofilms, bioburden, and senesent cells: role of biofilms in osteomyelitis and wound failure. Paper presented at: Diabetic Limb Salvage Conference; September 24. ,2009. ; Washington, DC.
Bowling FL, Stickings DS, Edwards-Jones V, et al: Hydrodebridement of wounds: effectiveness in reducing wound bacterial contamination and potential for air bacterial contamination. .J Foot Ankle Res 2::13. ,2009. .
Caselli A, Latini V, Lapenna A, et al: Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. .Diabet Med 22::460. ,2005. .
Game F: The advantages and disadvantages of non-surgical management of the diabetic foot. .Diabetes Metab Res Rev 24: (suppl 1):S72. ,2008. .
Enoch S, Grey JE, Harding KG: ABC of wound healing: non-surgical and drug treatments. .BMJ 332::900. ,2006. .
Klasen HJ: A review of the nonoperative removal of necrotic tissue from burn wounds. .Burns 26::207. ,2000. .
Davies CE, Turton G, Woolfrey G, et al: Exploring debridement options for chronic venous leg ulcers. .Br J Nurs 14::393. ,2005. .
Singhal A, Reis ED, Kerstein MD: Options for nonsurgical debridement of necrotic wounds. .Adv Skin Wound Care 14::96. ,2001. .
Sherman RA: Maggot therapy for foot and leg wounds. .Int J Low Extrem Wounds 1::135. ,2002. .
Sherman RA, Shapiro CE, Yang RM: Maggot therapy for problematic wounds: uncommon and off-label applications. .Adv Skin Wound Care 20::602. ,2007. .
Tantawi TI, Gohar YM, Kotb MM, et al: Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. .J Wound Care 16::379. ,2007. .
Dumville JC, Worthy G, Bland JM, et al: VenUS II team: Larval therapy for leg ulcers (VenUS II): randomized controlled trial. .BMJ 338::b773. ,2009. .
Bell AL, Cavorsi J: Noncontact ultrasound therapy for adjunctive treatment of nonhealing wounds: retrospective analysis. .Phys Ther 88::1517. ,2008. .
Ramundo J, Gray M: Is ultrasonic mist therapy effective for debriding chronic wounds?. J Wound Ostomy Continence Nurs 35::579. ,2008. .
Hinchliffe RJ, Valk GD, Apelqvist J, et al: A systemic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. .Diabetes Metab Res Rev 24: (suppl 1):S119. ,2008. .
Ennis WJ, Foremann P, Mozen N, et al: Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study. .Ostomy Wound Manage 51::24. ,2005. .
Ennis WJ, Valdes W, Gainer M, et al: Evaluation of clinical effectiveness of MIST ultrasound therapy for the healing of chronic wounds. .Adv Skin Wound Care 19::437. ,2006. .
Panuncialman J, Falanga V: The science of wound bed preparation. .Clin Plast Surg 34::621. ,2007. .
Sheehan P, Jones P, Giurini JM, et al: Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. .Plast Reconstr Surg 117: (suppl):239S. ,2006. .
The utility of wound debridement has expanded to include the management of all chronic wounds, even in the absence of infection and gross necrosis. Biofilms, metalloproteases on the wound base, and senescent cells at the wound edge irreversibly change the physiologic features of wound healing and contribute to a pathologic, chronic inflammatory environment. The objective of this review is to provide surgeons with a basic understanding of the processes of debridement in the noninfected wound. (J Am Podiatr Med Assoc 100(5): 353–359, 2010)